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As the coronavirus disease 2019
(COVID-19) outbreak began spreading
in Europe and the USA, a chart started
circulating online showing ratings
from the 2019 Global Health Security
Index, an assessment of 195 countries’
capacity to face infectious disease
outbreaks, compiled by the US-based
Nuclear Threat Initiative and the Johns
Hopkins School of Public Health’s
Center for Health Security. The USA
was ranked first, and the UK second;
South Korea was ranked ninth, and
China 51st; most African countries
were at the bottom of the ranking.
Things look different now. The US
and UK Governments have provided
among the world’s worst responses
to the pandemic, with sheer lies and
incompetence from the former, and
near-criminal delays and obfuscation
from the latter. Neither country
has widespread testing available,
as strongly recommended by WHO,
alongside treatment and robust
contact tracing.1 In neither country do
health workers have adequate access
to personal protective equipment;
nor are there nearly enough hospital
beds to accommodate the onslaught
of patients. Even worse, by refusing to
ease sanctions against Iran, Venezuela,
and Cuba, the US has crippled the
ability of other countries to respond,
continuing to block medical supplies
and other humanitarian aid.2
Meanwhile, Asian countries, including
China, South Korea, Singapore, and
Taiwan, have provided rapid, effective,
and often innovative responses, thanks
in part to their recent experience with
outbreaks of Middle East respiratory
syndrome in 2015 and the 2002–03
severe acute respiratory syndrome
epidemic. China has convened hundreds
of foreign officials to share lessons, and
dispatched experts, masks and other
supplies to Italy and other affected
countries. Cuba has also sent doctors to
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help with the response, and welcomed
sick cruise ship passengers refused
entry by the USA.
Although it is too early to assess
the strength of the COVID-19
response in Africa, African countries,
despite limited resources, have also
adopted measures worth imitating,
such as simplified triage strategies3
and proactive screening (Uganda),
handwashing stations at transport
hubs (Rwanda), WhatsApp chatbots
providing reliable information and
rapid testing diagnostics (Senegal),
and volunteer-staffed call centres
and celebrity campaigns to promote
responsible actions during the
pandemic (Nigeria). Yet relatively little
has been heard on the global stage
about these efforts or from African
veterans of the Ebola epidemics in
west Africa and central Africa, even
though COVID-19 appears to spread in
similar ways—through family clusters.
Is preparedness in the eye of the
beholder? COVID-19 is giving the lie
to prevailing notions of expertise and
solidarity. The global health model
is based in large part on technical
assistance and capacity building
by the US, the UK, and other rich
countries, whose response has been
sclerotic and delayed at best. A recent
report by Global Health 50/50 showed
that 85% of global organisations
working in health have headquarters
in Europe and North America;
two-thirds are headquartered in
Switzerland, the UK, and the USA. 4
More than 80% of global health
leaders are nationals of high-income
countries, and half are nationals of
the UK and the USA.
Global health will never be the
same after COVID-19—it cannot be.
The pandemic has given the lie to the
notion that expertise is concentrated
in, or at least best channelled by,
legacy powers and historically rich
states. We must move quickly, for
our own security, beyond the rhetoric
of equality to the reality of a more
democratic, more multipolar, more
networked, and more distributed

understanding and operation of global
health.
Conversations about how to do
so, although just beginning, are long
overdue.
I declare no competing interests.

Sarah L Dalglish
sdalgli1@jhu.edu

Gallo Images/Getty Images

COVID-19 gives the lie
to global health
expertise

Department of International Health, Johns Hopkins
School of Public Health, Baltimore, MD 21205, USA;
and Institute for Global Health, University College
London, London, UK
1
2

3

4

WHO. Critical preparedness, readiness and
response actions for COVID-19. Geneva:
World Health Organization, 2020.
Johnson J. Economists demand Trump
immediately lift Iran, Cuba, and Venezuela
sanctions that are ‘feeding the coronavirus
epidemic’. March 19, 2020. https://www.
commondreams.org/news/2020/03/19/
economists-demand-trump-immediately-liftiran-cuba-and-venezuela-sanctions-are
(accessed March 25, 2020).
Ayebare RR, Flick R, Okware S, Bodo B,
Lamorde M. Adoption of COVID-19 triage
strategies for low-income settings.
Lancet Resp Med 2020; published online
March 11. https://doi.org/10.1016/
S2213-2600(20)30114-4.
Global Health 50/50. The Global Health 50/50
Report 2020: power, privilege and priorities.
March, 2020. https://globalhealth5050.
org/2020report/ (accessed March 25, 2020).

A role for CT in
COVID-19? What data
really tell us so far
Radiologists have watched the
coronavirus disease 2019 (COVID-19)
pandemic unfold, wondering if and
how imaging could be useful for
diagnosis. Perhaps imaging could aid
in screening or accelerate the speed of
diagnosis, especially with shortages of
RT-PCR.
Some radiology literature suggests
a pivotal role for CT. Ai and colleagues1
report on 1014 patients who received
both RT-PCR and CT in Wuhan, China,
during their epidemic. They found
that 97% of cases with RT-PCR-con
firmed diagnoses had CT findings of
pneumonia, and conclude, “CT imaging
has high sensitivity for diagnosis of
COVID-19”. Other investigators are
less optimistic. Inui and colleagues2
reviewed CT scans of 112 cases of
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RT-PCR-confirmed COVID-19 from the
Diamond Princess cruise ship. Less than
two-thirds (61%) of cases had lung
opacities on CT; 20% of symptomatic
patients had negative CTs.
Although extremely valuable, these
results should not be overstated.
The CT findings studied (eg, groundglass opacity, consolidation) are not
specific for COVID-19. Similar results
would probably be found if CT were
used during an influenza epidemic,
for example. The positive predictive
value of CT will be low unless disease
prevalence is high, as we suspect it
was in Wuhan. Their cohort includes
“patients suspected of [COVID-19]”,2
presumably sick and possibly hos
pitalised, although details are not
provided.
RT-PCR to diagnose COVID-19
has some limitations: the test is not
universally available, turnaround
times can be lengthy, and reported
sensitivities vary. Nevertheless, it is the
accepted standard and only positive
in patients who are infected with
severe acute respiratory syndrome
coronavirus 2. CT findings in patients
with COVID-19, on the other hand, are
seen with numerous pathogens and
in many non-infectious aetiologies.
We believe CT does not add diagnostic
value; positive results can only be
believed if the pre-test probability of
disease is high. Using CT diagnostically
is not known to provide clinical benefit
and could lead to false security if
results are negative. If COVID-19 is
suspected, patients should be isolated
pending confirmation with (multiple)
RT-PCR tests, or until quarantine has
lapsed. The results of a CT scan do not
change this.
We feel that framing CT as pivotal
for COVID-19 diagnosis is a distraction
during a pandemic, and possibly
dangerous. Safely using CT to study
COVID-19 patients is logistically chal
lenging and can overwhelm available
resources. Even with proper cleaning
protocols, health-care professionals
and CT scanners could become vec
tors of infection to other vulnerable

patients who require imaging. We
urge caution and encourage using
published guidelines3 regarding use of
CT imaging.
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Dementia care during
COVID-19
Older adults are vulnerable at the onset
of natural disasters and crisis, and this
has been especially true during the
coronavirus disease 2019 (COVID-19)
pandemic.1 With the aggressive spread
of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the death
toll has risen worldwide. According
to an interactive online tool that
estimates the potential number of
deaths from COVID-19 in a population,
by age group, in individual countries
and regional groupings worldwide
under a range of scenarios, most of

those who have died were older adults,
most of whom had underlying health
problems.2
Globally, more than 50 million people
have dementia, and one new case occurs
every 3 s.3 Dementia has emerged as
a pandemic in an ageing society.4 The
double hit of dementia and COVID-19
pandemics has raised great concerns for
people living with dementia.
People living with dementia
have limited access to accurate
infor
m ation and facts about the
COVID-19 pandemic. They might have
difficulties in remembering safeguard
procedures, such as wearing masks,
or in understanding the public health
information issued to them. Ignoring
the warnings and lacking sufficient
self-quarantine measures could expose
them to higher chance of infection.
Older people in many countries, unlike
in China, tend to live alone or with their
spouse, either at home or in nursing
homes. As more and more businesses
stop non-essential services or initiate
telecommuting work in an attempt to
maintain social distancing and limit the
further spread of SARS-CoV-2, people
living with dementia, who have little
knowledge of telecommunication and
depend primarily on in-person support
might feel lonely and abandoned, and
become withdrawn.
To lessen the chance of infection
among older people in nursing homes,
more local authorities are banning
visitors to nursing homes and longterm care facilities.5 In January, 2020,
the Chinese Ministry of Civil Affairs
implemented similar social-distancing
measures.6 As a result, older residents
lost face-to-face contact with their
family members. Group activities in
nursing homes were also prohibited. As
a consequence, the residents of nursing
homes became more socially isolated.
We have observed that under the dual
stress of fear of infection and worries
about the residents’ condition, the level
of anxiety among staff in nursing homes
increased and they developed signs of
exhaustion and burnout after a monthlong full lockdown of the facilities.
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